mechanism

amyloid_clearance

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about amyloid_clearance: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections

18Hypotheses

7Analyses

0Outgoing

4Incoming

8Experiments

7Debates

Summary

A mechanism referenced in 2 knowledge graph relationships. Key connections: phagocytosis (mechanism) promotes; protective_against alzheimers (disease).

View on Wiki →

No AI portrait yet

⚙ Mechanism Info

Name	amyloid_clearance
Key Genes/Proteins	ACE, apolipoprotein_E
Linked Hypotheses	21 hypotheses

Pathway Diagram

graph TD
    amyloid_clearance["amyloid_clearance"]
    apolipoprotein_E("apolipoprotein_E")
    apolipoprotein_E -->|"regulates"| amyloid_clearance
    APOE4_domain_interaction["APOE4_domain_interaction"]
    APOE4_domain_interaction -->|"impairs"| amyloid_clearance
    ACE["ACE"]
    ACE -->|"enhances"| amyloid_clearance

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (4)

Source	Relation	Type	Str
apolipoprotein_E	regulates	protein	0.80
APOE4_domain_interaction	impairs	structural_defect	0.80
microglia	performs	cell_type	0.70
ACE	enhances	gene	0.50

Targeting Hypotheses (18)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Closed-loop transcranial focused ultrasound to restore hippo	0.827	Alzheimer's disease	Circuit-level neural dynamics in neurode
Test: TREM2 enhances amyloid clearance	0.755	-	-
Test: TREM2 enhances amyloid clearance	0.712	-	-
Test: TREM2 enhances amyloid clearance	0.705	-	-
Test: TREM2 enhances amyloid clearance	0.655	-	-

Test: TREM2 enhances amyloid clearance	0.637	-	-
Test: TREM2 enhances amyloid clearance	0.612	-	-
Closed-loop transcranial focused ultrasound to restore hippo	0.564	Alzheimer's disease	Circuit-level neural dynamics in neurode
Test: TREM2 enhances amyloid clearance	0.555	-	-
Test: TREM2 enhances amyloid clearance	0.537	-	-
Test: TREM2 enhances amyloid clearance	0.512	-	-
Test: TREM2 enhances amyloid clearance	0.437	-	-
Test: TREM2 enhances amyloid clearance	0.405	-	-
Test: TREM2 enhances amyloid clearance	0.400	-	-
Test: TREM2 enhances amyloid clearance	0.400	-	-
Test: TREM2 enhances amyloid clearance	0.400	-	-
Test: TREM2 enhances amyloid clearance	0.400	-	-
Test: TREM2 enhances amyloid clearance	0.400	-	-

Mentioning Analyses (7)

Scientific analyses that reference this entity

How does HDAC1/2 deletion specifically enhance microglial amyloid phagocytosis c

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.444

Is C1q elevation in AD pathogenic or compensatory for amyloid clearance?

neurodegeneration | 2026-04-12 | 0 hypotheses

Does SPP1-mediated synaptic engulfment represent beneficial clearance or patholo

synaptic biology | 2026-04-07 | 7 hypotheses Top: 0.708

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

neurodegeneration | 2026-04-03 | 45 hypotheses Top: 0.990

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

neurodegeneration | 2026-04-03 | 18 hypotheses Top: 0.847

Experiments (8)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Model	Status	Est. Cost
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.750	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.750	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.750	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.750	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.750	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.750	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.750	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.750	Mouse (5xFAD/TREM2-/-)	completed	N/A

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (7)

Multi-agent debates referencing this entity

While SPP1 absence prevents synaptic loss, it's unclear whether this represents

closed · Rounds: 4 · Score: 0.69 · 2026-04-21

The debate revealed conflicting evidence about C1q's role - some studies show it

closed · Rounds: 4 · Score: 0.58 · 2026-04-16

While the study shows HDAC1/2 deletion improves amyloid clearance and cognition,

closed · Rounds: 4 · Score: 0.95 · 2026-04-13

Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% brain penetrance. Engi

closed · Rounds: 4 · Score: 0.91 · 2026-04-06

APOE4 differs from APOE3 by C112R causing domain interaction that alters lipid b

closed · Rounds: 4 · Score: 0.89 · 2026-04-06

What gene expression changes in the aging mouse brain predict neurodegenerative

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transc

closed · Rounds: 4 · Score: 0.90 · 2026-04-03